AP Biosciences Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors (NCT07165067) | AP Biosciences Inc. | 2026-01-21 |
| A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors (NCT06669975) | AP Biosciences Inc. | 2025-04-22 |
| A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies (NCT05473156) | AP Biosciences Inc. | 2023-07-24 |
| A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors (NCT06723964) | AP Biosciences Inc. | 2023-03-30 |
Track AP Biosciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.